Navigation Links
Geron Demonstrates hESC-derived cardiomyocytes improve heart function after myocardial infarction
Date:8/27/2007

MENLO PARK, Calif., Aug. 27, 2007 Geron Corporation (Nasdaq: GERN) today reported its scientists and collaborators have demonstrated that human embryonic stem cell (hESC)-derived cardiomyocytes improve heart function when transplanted after myocardial infarction.

Published online Aug. 26 in Nature Biotechnology, the landmark study is the first to document the potential clinical utility of regenerating damaged heart muscle by injecting hESC-derived cardiomyocytes directly into the site of the infarct. In addition, the research confirms the effectiveness of a scalable production system that enables Geron to manufacture the cardiomyocytes for use in ongoing large animal studies and, ultimately, testing in humans.

The study describes the feeder- and serum-free, scalable production of hESC-derived cardiomyocytes, their survival in the infarct zone of rats when transplanted four days after infarction, and echocardiographic and MRI evidence of significant improvement in cardiac structure and contractile function. Gerons scientists conducted the study in collaboration with Charles Murry, M.D., Ph.D., and Michael Laflamme, M.D., Ph.D., at the University of Washington.

This is one of the most important publications on hESCs for Geron to date, said Thomas B. Okarma, Ph.D., M.D., Gerons president and chief executive officer. Our cardiomyocytes are the first human cardiac cells shown to survive after injection into an infarcted ventricle and to produce significant improvement in heart function. hESCs are the only cell type shown definitively to form cardiomyocytes.

Approximately 5.2 million people in the United States suffer from heart failure, and approximately 865,000 people experience myocardial infarction each year. About 36% of this population progresses to heart failure within five years of a first infarction. More than one-third of all heart failure patients die within two years of diagnosis.

Were developing our ca
'/>"/>

Contact: Sion Rogers
sion.rogers@russopartnersllc.com
212-845-4292
Russo Partners, LLC
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related biology news :

1. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
2. MRSA study demonstrates need for frequent hand washing and environmental disinfection in health care settings
3. Sangamo BioSciences demonstrates its ZFP treatment protects cells from HIV infection
4. New research demonstrates bone-marrow derived stem cells can reverse genetic kidney disease
5. Xie Lab demonstrates the role of microRNA pathway
6. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
7. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
8. Improved Outcomes Releases GeneLinker(TM) Gold and Platinum Version 4.6
9. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
10. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
11. Vascular structure and function improve with diet and exercise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2012)... the winners of their 6th Annual Research Awards ... the very best research that has been made ... guests attended the prestigious ceremony including leading researchers, ... world. , The winners were selected by ... journals which published more than 18,000 peer-reviewed open ...
(Date:5/17/2012)... participate in genetic testing that can indicate their ... these results does not appreciably drive up or ... health services, according to a study performed by ... colleagues at other institutions. , The study in ... Genetics in Medicine was done by ...
(Date:5/17/2012)... (BAPVC) an industry-supported program led by Stanford ... announced its first research grants aimed at making ... the decade. , A total of $7.5 million ... BAPVC partner institutions Stanford, UC-Berkeley, Lawrence Berkeley National ... National Renewable Energy Laboratory. , The three-year grants ...
Breaking Biology News(10 mins):BioMed Central announces winners of 6th Annual Research Awards 2NIH-led study finds genetic test results do not trigger increased use of health services 2NIH-led study finds genetic test results do not trigger increased use of health services 3NIH-led study finds genetic test results do not trigger increased use of health services 4Bay Area PV Consortium announces $7.5 million in grants to lower the cost of large-scale solar 2Bay Area PV Consortium announces $7.5 million in grants to lower the cost of large-scale solar 3Bay Area PV Consortium announces $7.5 million in grants to lower the cost of large-scale solar 4Study suggests lower risk of coronary heart disease from alcohol even with hazardous drinking 18988 1Study suggests lower risk of coronary heart disease from alcohol even with hazardous drinking 18988 2Study suggests lower risk of coronary heart disease from alcohol even with hazardous drinking 18988 3Study suggests lower risk of coronary heart disease from alcohol even with hazardous drinking 18988 4NIST prototypes framework for evaluating sustainability standards 18985 1NIST prototypes framework for evaluating sustainability standards 18985 2A less painful colonoscopy 81359 1A less painful colonoscopy 81359 2A less painful colonoscopy 81359 3
... can be lifted from Mother Nature, but a new paper* ... Standards and Technology (NIST) takes it to a cellular level. ... units of life, they argue that artificial cells could be ... eel cells but in fact improve on them. Artificial versions ...
... energy, the oil industry will need more refined tools for ... geologists say. , One such tool is a new sediment ... of the Paleozoic Era 542 to 251 million years ago, ... Science . The sediment curve covers the entire Paleozoic Era. ...
... Dunn Research Foundation has awarded a $3 million grant ... biomedical science that have the potential for clinical applications. ... researchers whose studies will be conducted at the Collaborative ... corner of University Boulevard and Main Street. To qualify ...
Other Biology News:Models of eel cells suggest electrifying possibilities 2Paleozoic 'sediment curve' provides new tool for tracking sea-floor sediment movements 2
(Date:5/16/2012)... May 16, 2012  Questcor Pharmaceuticals, Inc. (NASDAQ: ... Board of Directors has increased the Company,s common ... million shares. Since the beginning of ... shareholders through the repurchase of approximately 19.2 million ... its shares as of the commencement of the ...
(Date:5/15/2012)... Researchers have taken a step toward overcoming ... structures that could bring optical advances including ... The researchers have shown how to create ... gold previously required, said Alexandra Boltasseva, a ... computer engineering. , Using the metals is ...
(Date:5/15/2012)... -- Cardium Therapeutics (NYSE Amex: CXM ... first quarter ended March 31, 2012, and other ... In addition to the announcement ... its goals for 2012, which were outlined in ... advance commercialization of its new Excellagen® advanced, physician-use ...
(Date:5/14/2012)... connection, if any, between sudden cardiac death and people ... lives? , In a comprehensive, 10-year UCSF study, researchers ... a rate four times higher than the general population. ... we were looking at every instance of sudden death ... MD, an electrophysiologist and an associate professor of medicine ...
Breaking Biology Technology:Questcor Pharmaceuticals Expands Repurchase Program 2Questcor Pharmaceuticals Expands Repurchase Program 3Questcor Pharmaceuticals Expands Repurchase Program 4Questcor Pharmaceuticals Expands Repurchase Program 5New 'metamaterial' practical for optical advances 2New 'metamaterial' practical for optical advances 3Cardium Presents First Quarter 2012 Financial Results and Recent Developments 2Cardium Presents First Quarter 2012 Financial Results and Recent Developments 3Cardium Presents First Quarter 2012 Financial Results and Recent Developments 4Cardium Presents First Quarter 2012 Financial Results and Recent Developments 5Cardium Presents First Quarter 2012 Financial Results and Recent Developments 6Cardium Presents First Quarter 2012 Financial Results and Recent Developments 7Cardium Presents First Quarter 2012 Financial Results and Recent Developments 8Cardium Presents First Quarter 2012 Financial Results and Recent Developments 9Cardium Presents First Quarter 2012 Financial Results and Recent Developments 10Cardium Presents First Quarter 2012 Financial Results and Recent Developments 11Are people with HIV/AIDS more prone to sudden cardiac death? 2Are people with HIV/AIDS more prone to sudden cardiac death? 3
... , , Agencourt offers a full length insert sequencing ... and fosmids. Agencourt , has several features that allow us ... , Long Phred20 read lengths , ... SPRI technology , Oracle-based Galaxy LIMS , ...
... , , , , , ... purification system that uses a single protocol to purify a variety of high ... is easily automated , and produces high quality templates. The ... make CosMCPrep an ideal solution for all template , purification ...
... , , , , , , ... PCR clean up system capable , of purifying amplicons as small ... simple, three-step protocol requiring no centrifugation , or filtration steps. The ... 96 and 384-well formats. , , ...
Other Biology Technology:FULL LENGTH INSERT SEQUENCING 2COSMCPREP HIGH AND LOW COPY PLASMID PURIFICATION 2COSMCPREP HIGH AND LOW COPY PLASMID PURIFICATION 3AMPURE PURIFICATION SYSTEM 2AMPURE PURIFICATION SYSTEM 3
... system designed for flexibility and routine operation. ... ion lens, true hyperbolic quadrupole and high-speed ... widest range of sample types and applications. ... as standard Agilents unique ShieldTorch System, which ...
... except that it uses a deep-UV deuterium bulb, ... comes with a shutter (controlled via a TTL ... The DH-2000 Deuterium Tungsten Halogen Light Source ... halogen light sources in a single optical path. ...
... OPTIMA is a fully automated microplate ... the widest possible range of applications ... gene assays luciferase, -galactosidase, gene activities ... dioxetanes..) Luminescent Immunoassays Cell-based ...
One controller two vessel system suitable for early stage of fermentation, and small scale, Application : cultivation of microorganisms and human or animal cells...
Biology Products: